Search - tctmd.com

Displaying 721 - 740 of 1134

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Counterpoint: A "Selective" Minimalist Strategy Makes More Sense, and "Extreme" Minimalism Is Dangerous!

Presenter: Eberhard Grube, Howard C. Herrmann, Susheel K. Kodali

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve With Left Ventricular Outflow Tract Aneurysm

Presenter: A. Pieter Kappetein, Dee Dee Wang, Arijit Chanda, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Point: A Minimalist Strategy Should Be Used in ALL TAVR Patients!

Presenter: Eberhard Grube, Howard C. Herrmann, Vinod H. Thourani

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

ViV in a Patient With a "Ghost" Valve and Extremely Low Left Main Trunk Takeoff

Presenter: A. Pieter Kappetein, Dee Dee Wang, Costantino Costantini, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Contemporaneous Transcatheter Heart Valve Replacement in Native Aortic and Mitral Valve Stenosis

Presenter: Isaac George, Christopher U. Meduri, Marcus R. Burns

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

Presenter: Susheel K. Kodali, Michael J. Reardon, Patrick M. McCarthy

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Point: TAVR Will Be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

Presenter: Susheel K. Kodali, Michael J. Reardon, Mathew Williams

June 21, 2018

News Conference News The Structural Heart Disease Summit 2018

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

Shelley Wood

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

Presenter: Michael J. Mack, Bernard Prendergast

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

An Introduction to VARC-3: A Focused Update New Endpoints and Definitions for Aortic Valve Clinical Research

Presenter: Michael J. Mack, Nicolo Piazza

June 21, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Staffing the Structural Heart and Valve Center: The Roles of Cardiovascular Team Professionals

Presenter: Elizabeth M. Perpetua, Susan J. Schnell

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Simultaneous Transcatheter Aortic and Mitral Valve Replacement

Presenter: Patrick M. McCarthy, David Meerkin, Sachin Goel, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

SH Registry Update: TVT and LAAO

Presenter: Joan Michaels

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-making?

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Linda D. Gillam

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Using Novel Solutions to Treat Valvular Heart Disease

Presenter: Adam B. Greenbaum

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pick Your Poison: Complex Aortic Valve and Mitral Valve Disease

Presenter: Patrick M. McCarthy, David Meerkin, Vivian Ng, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Perspectives From the NEW Multisociety (AATS, ACCF, SCAI, and STS) Expert Consensus Statement on TAVR Operator and Institutional Requirements

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Carl L. Tommaso

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani, Stephan Windecker

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Surveying the Present and Future Landscape of AVR Therapy: A Patient-Centered Focus

Presenter: Daniel A Canos, Martin B. Leon, Vinod H. Thourani

June 21, 2018

Advertisement

Counterpoint: A "Selective" Minimalist Strategy Makes More Sense, and "Extreme" Minimalism Is Dangerous!

Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve With Left Ventricular Outflow Tract Aneurysm

Point: A Minimalist Strategy Should Be Used in ALL TAVR Patients!

ViV in a Patient With a "Ghost" Valve and Extremely Low Left Main Trunk Takeoff

Contemporaneous Transcatheter Heart Valve Replacement in Native Aortic and Mitral Valve Stenosis

Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

Point: TAVR Will Be the Treatment of Choice for Bicuspid Aortic Valve Disease in the Future!

Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR?

New Standards for SAVR and TAVR Bioprosthetic Valve Dysfunction and Failure: A Consensus Statement from EAPCI, ESC, and EACTS

An Introduction to VARC-3: A Focused Update New Endpoints and Definitions for Aortic Valve Clinical Research

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Staffing the Structural Heart and Valve Center: The Roles of Cardiovascular Team Professionals

Simultaneous Transcatheter Aortic and Mitral Valve Replacement

SH Registry Update: TVT and LAAO

Multisociety Appropriate Use Criteria for the Treatment of Patients With Severe Aortic Stenosis: A Useful Guide for Clinical Decision-making?

Using Novel Solutions to Treat Valvular Heart Disease

Pick Your Poison: Complex Aortic Valve and Mitral Valve Disease

Perspectives From the NEW Multisociety (AATS, ACCF, SCAI, and STS) Expert Consensus Statement on TAVR Operator and Institutional Requirements

TAVR and SAVR Therapy: Reconciling the Recent Society (ACC/AHA/ESC/EACTS) Guidelines With Clinical Practice Trends

Surveying the Present and Future Landscape of AVR Therapy: A Patient-Centered Focus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content